Results from a study of a technique known as focused ultrasound have shown a benefit for people with Parkinson’s with movement problems, for up to a year after treatment.
We've launched a new guide to help more people living with Parkinson's to enjoy a healthy and active lifestyle.
From 1 April, we're introducing the new role of Director of the Parkinson’s Virtual Biotech alongside the existing role of Director of Research.
A survey of over 4,000 people with long-term conditions, including those with Parkinson’s, on prescription charges, has found the charge is a barrier to accessing medicine.
An early phase clinical trial, funded by our supporters through the Parkinson's Virtual Biotech, suggests that the drug NLX-112 is safe and effective for people with Parkinson’s with levodopa-induced dyskinesias.
A brief analysis of what the Health and Disability White Paper means for people with Parkinson's.
On 15 March, chancellor Jeremy Hunt set out the government’s economic plans. Here’s our summary of the measures announced and their potential impact on people with Parkinson’s and their carers.
Researchers compared results from over 150 studies to understand how different types of physical activity can be used to manage Parkinson’s symptoms.
Research into how the brain works, and what happens when things go wrong, is vital to help us find better treatments for Parkinson’s.
Parkinson’s UK brought health leaders, clinicians, people with Parkinson’s and care partners together to discuss key challenges and solutions facing the Parkinson’s healthcare workforce.